Summer School on Neuroscience & Aging

Slides:



Advertisements
Similar presentations
Epidemiology of Dementia
Advertisements

APOE Genotype Effects on Alzheimer’s Disease Clinical Onset, Epidemiology, and Gompertzian Aging Functions J.Wesson Ashford, M.D., Ph.D. Stanford / VA.
Centre Cérébrovasculaire COMORBIDITY ANALYSIS AND 3 MONTHS FUNCTIONAL OUTCOME IN ACUTE ISCHEMIC STROKE: DATA FROM ACUTE STROKE REGISTRY AND ANALYSIS.
Epidemiology & Critical Thinking D. Morse st Avenue Tel: Office Hours: 4:00-5:00 (M & W)
Mild Cognitive Impairment as a Target for Drug Development Steven H. Ferris, Ph.D. Silberstein Aging and Dementia Research Center New York University School.
Cohort Studies Hanna E. Bloomfield, MD, MPH Professor of Medicine Associate Chief of Staff, Research Minneapolis VA Medical Center.
Periodontal Disease Risk Developed by PreViser, Inc. Courtesy PreViser Corporation, all rights reserved.
Introduction to Molecular Epidemiology Jan Dorman, PhD University of Pittsburgh School of Nursing
Dr. Omranifard MD 12 may 2015 Depression is one of the most prevalent psychiatric disorders in late life with devastating health consequences. It could.
BC Jung A Brief Introduction to Epidemiology - X (Epidemiologic Research Designs: Cohort Studies) Betty C. Jung, RN, MPH, CHES.
Summer 2012 Practicum Veliky Novgorod, Russia Julie Mooza Department of Epidemiology, University of Massachusetts.
Cohort Study.
The Nature of Disease.
Hui-Xin Wang, Stockholm, Oct Hui-Xin Wang, Ph.D Div. Geriatric Epidemiology Dept. NEUROTEC, Karolinska Institutet & Stockholm Gerontology Research.
CHP400: Community Health Program- lI Research Methodology STUDY DESIGNS Observational / Analytical Studies Case Control Studies Present: Disease Past:
Web of Causation; Exposure and Disease Outcomes Thomas Songer, PhD Basic Epidemiology South Asian Cardiovascular Research Methodology Workshop.
Lecture 6 Objective 16. Describe the elements of design of observational studies: (current) cohort studies (longitudinal studies). Discuss the advantages.
Genetic-Environmental Interaction: Implications for Osteoporosis Prevention Strategies.
Introduction to Epidemiology Instructor: Guan-Hua Huang, Ph.D. Class meetings: Wednesday 1:30-4:30.
Case-control study Chihaya Koriyama August 17 (Lecture 1)
Chapter 2 Nature of the evidence. Chapter overview Introduction What is epidemiology? Measuring physical activity and fitness in population studies Laboratory-based.
Do Instrumental Activities of Daily Living Predict Dementia at 1- and 2- Year Follow-Up? Findings from the Development of Screening Guidelines and Diagnostic.
Case Control Study Dr. Ashry Gad Mohamed MB, ChB, MPH, Dr.P.H. Prof. Of Epidemiology.
Adverse Outcomes After Hospitalization and Delirium in Persons with Alzheimer Disease Charles Wang, PharmD Candidate.
Epidemiological and Pharmacoeconomic Aspects of Alzheimer‘s Disease and Dementia.
Reading Health Research Critically The first four guides for reading a clinical journal apply to any article, consider: the title the author the summary.
Peripheral and Central Nervous System Drugs Advisory Committee Meeting - March 14, Issues Related to the Development of Drugs for the Treatment.
The Impact of Epidemiology in Public Health Robert Hirokawa, DrPH Epidemiologist, Science and Research Group HHI / TSP, Hawaii Department of Health.
Centers for Disease Control and Prevention National Center for Health Statistics Melonie Heron, Ph.D. & Robert N. Anderson, Ph.D. Mortality Statistics.
Screening – a discussion in clinical preventive medicine Galit M Sacajiu MD MPH.
Introduction to General Epidemiology (2) By: Dr. Khalid El Tohami.
Measures of disease frequency Simon Thornley. Measures of Effect and Disease Frequency Aims – To define and describe the uses of common epidemiological.
Methodological quality assessment of observational studies Nicole Vogelzangs Department of Psychiatry & EMGO + institute.
Epidemiological Study Designs And Measures Of Risks (1)
بسم الله الرحمن الرحيم  الحمد لله رب العالمين والصلاة والسلام علي سيدنا محمد الصادق الوعد الأمين ، اللهم أخرجنا من ظلمات الجهل والوهم ، إلى نور المعرفة.
Characterstic of disease
Scottish National Burden of Disease, Injuries and Risk Factors study:
Some epidemiological principles and methods
Descriptive Epidemiology According to Person, Place, and Time
Instructional Objectives:
Study Designs Group Work
Chihaya Koriyama August 17 (Lecture 1)
Common causes of dementia based on age at presentation and rate of progression. “Mixed” refers to combined Alzheimer disease and vascular dementia. Totals.
Present: Disease Past: Exposure
Hadley KEY SLIDES 9-5 7:45-8:15 PM
Matched Case-Control Study
بسم الله الرحمن الرحيم الحمد لله رب العالمين والصلاة والسلام علي سيدنا محمد الصادق الوعد الأمين ، اللهم أخرجنا من ظلمات الجهل والوهم ، إلى نور المعرفة.
Changing demographics and the impact on dementia
M. M. Dumitru¹∙², V.Chirita¹∙², R.Chirita¹∙²
Neural.
Study design.
Common causes of dementia based on age at presentation and rate of progression. “Mixed” refers to combined Alzheimer disease and vascular dementia. Totals.
Dementia Risk Prediction Development of the first tool for LMICs (WS2)
Figure 3 Life expectancy at birth in all countries included
Some Epidemiological Studies
PPMI in the Medical Literature
John F. Crary, MD-PhD Associate Professor
Does Multilingualism Protect Against Alzheimer’s Disease
Epidemiology MPH 531 Analytic Epidemiology Case control studies
Mpundu MKC MSc Epidemiology and Biostatistics, BSc Nursing, RM, RN
Critical Appraisal วิจารณญาณ
Interaction When the incidence of a disease in the presence of two or more risk factors differs from the incidence rate expected to result from their individual.
Epidemiology of Dementias
Objectives: To know the different types and varieties of designs that are commonly used in medical researches. To know the characteristics, advantages.
HEC508 Applied Epidemiology
Study Designs-Review Epidemiology 200A Dr. Jørn Olsen
Dr Luis E Cuevas – LSTM Julia Critchley
Effect Modifiers.
Sources of health outcomes data used in the SJLIFE study where severity grading criteria of long-term and late-onset health events were applied. Sources.
Presentation transcript:

Summer School on Neuroscience & Aging Venice, 10 - 15 June 2013 Prevention of the dementing disorders: from observation to intervention Laura Fratiglioni www.ki-su-arc.se

Outline Part I (30 min +10 for discussion) Methodological issues: clinical and epidemiological A model for dementia development Part II (30 min +10 for discussion) 3. Risk factors 4. Protective factors 5. Summary-current knowledge Part III (20 min +10 for discussion) 6. Future perspectives 31 December 2018 Laura Fratiglioni

METHODOLICAL ISSUES IN THE EPIDEMIOLOGY OF DEMENTIA PART I METHODOLICAL ISSUES IN THE EPIDEMIOLOGY OF DEMENTIA PROTECTING THE HUMAN BRAIN AND REDUCING THE RISK OF DEMENTIA Laura Fratiglioni Laura Fratiglioni www.ki-su-arc.se

Epidemiology of Dementia & AD: Topics Descriptive epidemiology Etiological epidemiology Clinical epidemiology Occurrence Public health Etiology Risk factors Diagnosis Markers Prognosis Natural history Laura Fratiglioni 31 December 2018 3

Dementia: challenging issues Disease of the older people Diagnostic validity Underreport in official statistics Hospitalization for selected cases Slow and insidious onset Presence of co-morbidity Multifactorial Lifespan risk Laura Fratiglioni 31 December 2018 3

Disease of the older people Laura Fratiglioni 31 December 2018 3

Disease of the older people Drop-outs due weakness and disease Attrition both at baseline and follow-up Misclassification of the exposure, especially in case control studies - recall bias - unbalance exposure assessment Competing risk of death Laura Fratiglioni 31 December 2018 3

The Kungsholmen Project Baseline 1st follow-up 2nd follow-up 3rd follow-up 4th follow-up 1987-1989 1991-1993 1994-1996 1997-1998 1999-2000 1

The Kungsholmen Project 1810 Participants 23.6% Drop-outs 1099 Participants 24% Deceased 15.5% Drop-outs 680 Participants 33% Deceased 5% Drop-outs 421 Participants 32% Deceased 6% Drop-outs 265 Participants 30% Deceased 7% Drop-outs 1987-89 1991-93 1994-96 1997-98 1999-2000 Baseline 1st Follow-up 2nd Follow-up 3rd Follow-up 4th Follow-up 1

Dementia: challenging issues Disease of the older people Diagnostic validity Underreport in official statistics Hospitalization for selected cases Slow and insidious onset Presence of co-morbidity Multifactorial Lifespan risk Laura Fratiglioni 31 December 2018 3

Diagnostic validity No biological markers Variability Missing mild/early cases Selection bias Misclassification of the outcome decreased power bias Laura Fratiglioni 31 December 2018 3

Rethinking the classification of degenerative and vascular cases One challenge is the overlapping between AD and VaD. 55% mixed; AD with vascular involvment or VaD with AD type of course. 75+ Viswanathan, Rocca, Tzourio, Neurology, May 2009 Kalaria R et al. Alzheimer Dis Assoc Disord 1999 Aguero-Torres et al, 2001 12 12

Distribution of dementia subtypes: incident cases MIXED DEMENTIA Longitudinal studies on dementia in Europe (Fratiglioni et al, Neurology 2000) Distribution of dementia subtypes: incident cases MIXED CASES Aguero-Torres, 2001

Neuropathology of Alzheimer Disease and MCI Schneider et al Ann Neurol 2009 Mixed dementia

Age, Neuropathology, and Dementia Savva et al, NEJM 2009 Mixed dementia

Dementia: challenging issues Disease of the older people Diagnostic validity Underreport in official statistics Hospitalization for selected cases Slow and insidious onset Presence of co-morbidity Multifactorial Lifespan risk Laura Fratiglioni 31 December 2018 3

Underreport in official statistics Population IPR + CDR Prevalent cases KP 50.2 (47.7-52.8) Incident cases KP 47.9 (45.3-50.6) Prev. cases SNAC-K 42.1 (40.3-43.9) Laura Fratiglioni 31 December 2018 3

Dementia: challenging aspects Underreport in official statistics Hospitalization for selected cases Selection bias Misclassification of the outcome decreased power bias Laura Fratiglioni 31 December 2018 3

Dementia: challenging issues Disease of the older people Diagnostic validity Underreport in official statistics Hospitalization for selected cases Slow and insidious onset Presence of co-morbidity Multifactorial Lifespan risk Laura Fratiglioni 31 December 2018 3

CIND

Social network and AD STUDY POPULATION Detection of incident cases Fratiglioni et al, Lancet 2000 STUDY POPULATION Detection of incident cases Assessment of social network 1203 non-demented persons 176 demented subjects Baseline 1987 - 1989 1st follow-up 1991 - 1993

Leisure activities & dementia Wang et al, Am J Epidemiol 2002 STUDY POPULATION Assessment of engagement in leisure activities Detection of incident cases 776 non demented 123 demented Baseline 1987 - 1989 1st follow-up 1991-1993 2nd follow-up 1994 - 1996

Dementia: challenging aspects Slow and insidious onset Precipitating rather than risk factors Reverse causality Laura Fratiglioni 31 December 2018 3

Dementia: challenging issues Disease of the older people Diagnostic validity Underreport in official statistics Hospitalization for selected cases Slow and insidious onset Presence of co-morbidity Multifactorial Lifespan risk Laura Fratiglioni 31 December 2018 3

54.8% Multimorbidity (2+ diseases) Most common chronic disorders among 75+ old people Multimorbidity (2+ diseases)   54.8% (50.8-58.8) Marengoni et al, Am J Publ Health 2008

Age-specific prevalence per 100 for number of chronic diseases No diseases %

Dementia: challenging issues Disease of the older people Diagnostic validity Underreport in official statistics Hospitalization for selected cases Slow and insidious onset Presence of co-morbidity Multifactorial Lifespan risk Laura Fratiglioni 31 December 2018 3

Brain Reserve Capacity Risk Factors: biological & contextual Vascular mechanisms Neuro- degeneration Toxicity Oxidative stress Inflammation Genetic background Birth Childhood- Adult life- Older 2nd decade Middle age Transition age Brain lesions 20 60 75 Brain Reserve Capacity Psychosocial factors Nutrition Protective Factors

Dementia: challenging aspects Disease of the older people Questionable diagnostic validity Underreport in official statistics Hospitalization for selected cases Slow and insidious onset Presence of co-morbidity Multifactorial Life span Life time cumulative exposure Exposure windows Laura Fratiglioni 31 December 2018 3

Dementia: challenging aspects Disease of the older people Questionable diagnostic validity Underreport in official statistics Hospitalization for selected cases Slow and insidious onset Presence of co-morbidity Multifactorial Lifespan risk Study population Study design Drop-outs Case detection Diagnosis Exposure Confounders Bias Power Temporal relation 3

Epidemiological evidence in dementia SBU 2005 Wang & Fratiglioni JAD 2007 Internal validity index 4 grades (not-acceptable; low, medium; high) 9 items (Population types, Design,Drop-outs, Case detection, Diagnosis,Exposure, Confounders, Bias, Power) Causal criteria index 4 grades (not-acceptable; low, medium; high) 3 items (Strength, Temporality, Biolog. gradient)

Epidemiological evidence in dementia Grading the evidence Quantity Low Medium High Insufficient Limited Moderate Substantial Strong Final quality index

Questions